Funding for this research was provided by:
Dutch Ministry of Economic Affairs, Friesland Campina, and Innopastry (TKI-AF-15206, TKI-AF-15206)
Received: 2 August 2021
Accepted: 9 December 2021
First Online: 9 March 2022
: The ProMuscle (Trial Registration: clinicaltrials.gov identifier: NCT01110369) and ProMuscle in Practice (Netherlands Trial Register; NTR6038) studies were approved by Wageningen University Medical Ethical Committee. No medical ethical approval was needed for the ProMuscle Implementation Pilots as this research did not fall within the remit of the Dutch ‘Medical Research Involving Human Subjects Act’ (in Dutch: WMO). All methods were carried out in accordance with relevant guidelines and regulations.
: Participants of ProMuscle and ProMuscle in Practice gave their written informed consent before participation. For the ProMuscle Implementation Pilots, consent was provided according to physiotherapists’ standard working procedures (opt-in) on sharing data of patients or participants (according to the Royal Dutch Society of Physiotherapy) [CitationRef removed]. As part of this procedure oral consent was obtained by all participants. The physiotherapist provided written informed consent for gaining oral informed consent from participants.
: The authors declare that they have no competing interests.